The FCA continues to be the federal government’s primary civil enforcement tool for investigating allegations that healthcare providers or government contractors defrauded the federal government. In the coming weeks, we are...more
The government’s FCA enforcement efforts have continued to focus on key areas concerning the pharmaceutical and medical device industries. In fact, drug and device manufacturers accounted for nearly half of the enforcement...more
5/16/2017
/ Anti-Kickback Statute ,
Discount Pricing ,
False Claims Act (FCA) ,
Fraud ,
GlaxoSmithKline ,
Health Insurance ,
Medical Devices ,
Off-Label Promotion ,
Pfizer ,
Pharmaceutical Industry ,
Pharmacies ,
Physicians ,
Prescription Drugs ,
RICO
The FCA continues to be the federal government’s primary civil enforcement tool for investigating allegations that healthcare providers or government contractors defrauded the federal government. In the coming weeks, we are...more
Physician employment arrangements with hospitals have remained a significant area of regulatory scrutiny in recent months with the announcement of several high profile settlements and decisions in key FCA cases involving...more
5/5/2017
/ Anti-Kickback Statute ,
Employment Contract ,
False Claims Act (FCA) ,
Healthcare Facilities ,
Hospitals ,
Medicare ,
Physicians ,
Referral Fees ,
Relators ,
Settlement ,
Stark Law
The FCA continues to be the federal government’s primary civil enforcement tool for investigating allegations that healthcare providers or government contractors defrauded the federal government. In the coming weeks, we are...more
Bass, Berry & Sims is pleased to announce the release of its fifth annual Healthcare Fraud and Abuse Review 2016. The Review, compiled by the firm’s Healthcare Fraud Task Force, is an industry-leading guide to healthcare...more
4/13/2017
/ 60-Day Rule ,
Anti-Kickback Statute ,
Damages ,
Enforcement Actions ,
False Claims Act (FCA) ,
False Implied Certification Theory ,
Fraud and Abuse ,
Healthcare Fraud ,
HITECH Act ,
Hospice ,
Hospitals ,
Individual Accountability ,
Long Term Care Facilities ,
Managed Care Contracts ,
Materiality ,
Medical Devices ,
Off-Label Promotion ,
Overpayment Recovery Time Limits ,
Pharmaceutical Industry ,
Pharmacies ,
Physicians ,
Pleading Standards ,
Public Disclosure ,
Qui Tam ,
Relators ,
Retaliation ,
Reverse False Claims ,
Scienter ,
Settlement Agreements ,
Skilled Nursing Facility ,
Stark Law ,
Universal Health Services Inc v United States ex rel Escobar ,
Yates Memorandum
After granting the relators’ petition for an interlocutory review of the district court’s rejection of the use of statistical sampling to establish FCA liability, the Fourth Circuit ultimately declined to reach that issue in...more
2/22/2017
/ Administrative Authority ,
Attorney General ,
Department of Justice (DOJ) ,
False Billing ,
False Claims Act (FCA) ,
Hospice ,
Interlocutory Appeals ,
Qui Tam ,
Relators ,
Settlement ,
Statistical Sampling ,
Veto Rights